Results 161 to 170 of about 778,750 (285)

Adipose Tissue-Derived Small Extracellular Vesicles in Plasma Reveal Molecular Circuitries Underlying Glucose Intolerance. [PDF]

Obesity (Silver Spring)
Mishra S, Su Y, Kumar A, Singh S, Finlin BS, Hsu FC, Lee J, Furdui CM, Kern PA, Das SK, Deep G.   +10 more
europepmc   +1 more source

Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST‐T1D Extension Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate changes in glycaemic control following semaglutide discontinuation in adults with Type 1 diabetes and obesity who completed the ADJUST‐T1D randomised controlled trial. Materials and Methods Continuous glucose monitoring (CGM) data were collected during a 12‐week extension phase after the ADJUST‐T1D trial.
Eslam Montaser, Kanchan Bhasin, Davida Kruger, Halis Kaan Akturk, Andrew Ahmann, Janet K. Snell‐Bergeon, Viral N. Shah   +6 more
wiley   +1 more source

The attenuated incretin effect is associated with glucose intolerance in patients with hepatitis B-related acute-on-chronic liver failure. [PDF]

Front Physiol
Li M, Hu H, Liu Y, Wu X, Zhang Y, Li Y, Yang F, Li Y, Lin S.   +8 more
europepmc   +1 more source

Real‐World Evidence for Existing Anti‐Obesity Therapies—The Realities of Treatment Adherence, Tolerability, Access and Patient Satisfaction

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Obesity is associated with substantial cardiometabolic and psychosocial morbidity. Although randomized controlled trials demonstrate the efficacy of anti‐obesity therapies, outcomes in real‐world practice may be attenuated due to limited access, tolerability, adherence and insufficient long‐term support.
Sameer Kassem
wiley   +1 more source

Study of association between serum anti-Müllerian hormone, glucose intolerance, and metabolic syndrome in women with polycystic ovarian syndrome: A comparative study. [PDF]

Int J Gynaecol Obstet
Kondaguli NA, A P.
europepmc   +1 more source

The SGLT2i Treatment Gap in UK Primary Care: A Cross‐Sectional RWE Study of Prescribing in Clinical Practice

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Sodium‐glucose co‐transporter 2 inhibitors (SGLT2i) improve cardiovascular and renal outcomes in type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD) and chronic heart failure (CHF). Despite clinical guideline recommendations, SGLT2i uptake in UK primary care remains suboptimal and information on utilisation is limited.
Chelsea Stefanska, Ryan Chung, Salman Ramjaun, Danyao Jin, Ciara Doherty, Kieran McCafferty, Samuel Seidu   +6 more
wiley   +1 more source

Reduced platelet count in mice protects against glucose intolerance and beta cell loss during a long-term high-fat diet. [PDF]

Front Immunol
Burkhard N, Hoch J, Zhang S, Hamad MA, Schommer N, Mogler C, Stallmann D, Mangin P, Krauel K, Duerschmied D, Schanze N.   +10 more
europepmc   +1 more source

GLP‐1 Receptor Agonists Post‐Bariatric Surgery (GRABS) Trial: Rationale, Design and Baseline Characteristics

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims No studies have investigated the synergistic effectiveness of Glucagon‐Like Peptide 1 Receptor Agonists (GLP1RAs) in patients with persistent obesity following bariatric surgery. The GLP‐1 Receptor Agonists Post‐Bariatric Surgery (GRABS) Trial aims to investigate the effectiveness of tirzepatide (TRZ) versus standard of care (SOC) after ...
J. M. Samuels, C. R. Williams, M. B. Patel, W. H. Self, L. M. Funk, C. Roumie, M. D. Spann, C. J. Northup, F. Ye, R. Irlmeier, I. Sohn, Y. Zhu, K. Niswender   +12 more
wiley   +1 more source

A Short-Term High-Sugar Diet Induces Glucose Intolerance, Visceral Adipose Tissue Inflammation, and Exacerbates Experimental Allergic Asthma. [PDF]

Nutrients
Casaro MC, de Souza V, Mendes E, Pereira JC, Oliveira FA, Ferreira CM.   +5 more
europepmc   +1 more source

Impact of COVID-19 restrictions and their relaxation on body composition and glycemic control in individuals with glucose intolerance in Japan: A single-center observational study. [PDF]

J Diabetes Investig
Kobayashi A, Keidai Y, Murakami T, Tsukaguchi R, Fujita M, Wada K, Yabe D.   +6 more
europepmc   +1 more source